Sydney startup Medow Health AI, which uses artificial intelligence to automate medical reports for specialist doctors, has raised $3 million in new funding. The money came from the same clinicians who invested in the company’s first round earlier this year.
Medow Health was cofounded by brothers Joel and Josh Freiberg. Joel has Crohn’s disease, and they were inspired to start the company after seeing how much extra admin work their father, a respiratory doctor, had to do after hours.
The startup earlier raised $2 million in January from investors including Chris O’Brien Lifehouse CEO Dr Michael Boyer, orthopaedic surgeon Dr Michael Solomon, and eye surgeon Dr Johnny Wu—all of whom reinvested in this new round.
Revenue has grown 300% in 2025, and the platform’s AI now processes more than 100,000 specialist consultations every month. It also completed a successful pilot at a major Australian hospital.
Medow Health has expanded to New Zealand and Southeast Asia, where Joel Freiberg says the company has seen strong adoption in both markets.
“The capital raise will enable us to launch new AI products to specialist medical communities across the country, increase integrations into key healthcare systems and see us through to profitability within 12 months,” he said.
“We didn’t have to look far for investors for both the initial and second round capital raise with our early medical specialist customers already using the technology wanting to be involved.”
“Where others only focus on AI we use our engineering talent to integrate with key medical systems, recently launching a tailored hospital product for meditech powered Chris O’Brien Lifehouse,” he said.
Read more- Sophrosyne Technologies raises $2 million Seed round
